Cargando…

To explore the Radix Paeoniae Rubra-Flos Carthami herb pair's potential mechanism in the treatment of ischemic stroke by network pharmacology and molecular docking technology

To explore the Radix Paeoniae Rubra-Flos Carthami herb pair's (RPR-FC) potential mechanism in treating ischemic stroke (IS) by network pharmacology and molecular docking technology. The Traditional Chinese Medicine Systems Pharmacology Database was used to screen the active components of the RP...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xingyu, Wang, Yue, Ma, Ying, Wang, Ruonan, Zhao, Dexi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8663872/
https://www.ncbi.nlm.nih.gov/pubmed/34889224
http://dx.doi.org/10.1097/MD.0000000000027752
_version_ 1784613738432692224
author Chen, Xingyu
Wang, Yue
Ma, Ying
Wang, Ruonan
Zhao, Dexi
author_facet Chen, Xingyu
Wang, Yue
Ma, Ying
Wang, Ruonan
Zhao, Dexi
author_sort Chen, Xingyu
collection PubMed
description To explore the Radix Paeoniae Rubra-Flos Carthami herb pair's (RPR-FC) potential mechanism in treating ischemic stroke (IS) by network pharmacology and molecular docking technology. The Traditional Chinese Medicine Systems Pharmacology Database was used to screen the active components of the RPR-FC, and Cytoscape 3.8 software was used to construct a network map of its active components and targets of action. The GeneCards and OMIM databases were used to identify disease targets of IS, and the common targets were chosen as research targets and imported into the STRING database to construct a protein–protein interaction network map of these targets. R language software was used to analyze the enrichment of GO terms and KEGG pathways, and explore the mechanisms of these targets. Molecular docking technology was used to verify that the RPR-FC components had a good bonding activity with their potential targets. A total of 44 active components, which corresponded to 197 targets, were identified in the RPR-FC. There were 139 common targets between the herb pair and IS. GO functional enrichment analysis revealed 2253 biological process entries, 72 cellular components entries, and 183 molecular functions entries. KEGG pathway enrichment analysis was mainly related to the NF-kappa B signaling pathway, the TNF signaling pathway, apoptosis, the MAPK signaling pathway, the PI3K-Akt signaling pathway, the VEGF signaling pathway, etc. The molecular docking results showed the components that docked well with key targets were quercetin, luteolin, kaempferol, and baicalein. The active components (quercetin, luteolin, kaempferol, and baicalein) of the RPR-FC and their targets act on proteins such as MAPK1, AKT1, VEGFA, and CASP3, which are closely related to IS.(1) These targets are closely related to the NF-kappa B signaling pathway, the MAPK signaling pathway, the PI3K-Akt signaling pathway, the VEGF signaling pathway, and other signaling pathways. These pathways are involved in the recovery of nerve function, angiogenesis, and neuronal apoptosis and the regulation of inflammatory factors, which may have a therapeutic effect on IS.
format Online
Article
Text
id pubmed-8663872
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-86638722021-12-13 To explore the Radix Paeoniae Rubra-Flos Carthami herb pair's potential mechanism in the treatment of ischemic stroke by network pharmacology and molecular docking technology Chen, Xingyu Wang, Yue Ma, Ying Wang, Ruonan Zhao, Dexi Medicine (Baltimore) 3800 To explore the Radix Paeoniae Rubra-Flos Carthami herb pair's (RPR-FC) potential mechanism in treating ischemic stroke (IS) by network pharmacology and molecular docking technology. The Traditional Chinese Medicine Systems Pharmacology Database was used to screen the active components of the RPR-FC, and Cytoscape 3.8 software was used to construct a network map of its active components and targets of action. The GeneCards and OMIM databases were used to identify disease targets of IS, and the common targets were chosen as research targets and imported into the STRING database to construct a protein–protein interaction network map of these targets. R language software was used to analyze the enrichment of GO terms and KEGG pathways, and explore the mechanisms of these targets. Molecular docking technology was used to verify that the RPR-FC components had a good bonding activity with their potential targets. A total of 44 active components, which corresponded to 197 targets, were identified in the RPR-FC. There were 139 common targets between the herb pair and IS. GO functional enrichment analysis revealed 2253 biological process entries, 72 cellular components entries, and 183 molecular functions entries. KEGG pathway enrichment analysis was mainly related to the NF-kappa B signaling pathway, the TNF signaling pathway, apoptosis, the MAPK signaling pathway, the PI3K-Akt signaling pathway, the VEGF signaling pathway, etc. The molecular docking results showed the components that docked well with key targets were quercetin, luteolin, kaempferol, and baicalein. The active components (quercetin, luteolin, kaempferol, and baicalein) of the RPR-FC and their targets act on proteins such as MAPK1, AKT1, VEGFA, and CASP3, which are closely related to IS.(1) These targets are closely related to the NF-kappa B signaling pathway, the MAPK signaling pathway, the PI3K-Akt signaling pathway, the VEGF signaling pathway, and other signaling pathways. These pathways are involved in the recovery of nerve function, angiogenesis, and neuronal apoptosis and the regulation of inflammatory factors, which may have a therapeutic effect on IS. Lippincott Williams & Wilkins 2021-12-10 /pmc/articles/PMC8663872/ /pubmed/34889224 http://dx.doi.org/10.1097/MD.0000000000027752 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/)
spellingShingle 3800
Chen, Xingyu
Wang, Yue
Ma, Ying
Wang, Ruonan
Zhao, Dexi
To explore the Radix Paeoniae Rubra-Flos Carthami herb pair's potential mechanism in the treatment of ischemic stroke by network pharmacology and molecular docking technology
title To explore the Radix Paeoniae Rubra-Flos Carthami herb pair's potential mechanism in the treatment of ischemic stroke by network pharmacology and molecular docking technology
title_full To explore the Radix Paeoniae Rubra-Flos Carthami herb pair's potential mechanism in the treatment of ischemic stroke by network pharmacology and molecular docking technology
title_fullStr To explore the Radix Paeoniae Rubra-Flos Carthami herb pair's potential mechanism in the treatment of ischemic stroke by network pharmacology and molecular docking technology
title_full_unstemmed To explore the Radix Paeoniae Rubra-Flos Carthami herb pair's potential mechanism in the treatment of ischemic stroke by network pharmacology and molecular docking technology
title_short To explore the Radix Paeoniae Rubra-Flos Carthami herb pair's potential mechanism in the treatment of ischemic stroke by network pharmacology and molecular docking technology
title_sort to explore the radix paeoniae rubra-flos carthami herb pair's potential mechanism in the treatment of ischemic stroke by network pharmacology and molecular docking technology
topic 3800
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8663872/
https://www.ncbi.nlm.nih.gov/pubmed/34889224
http://dx.doi.org/10.1097/MD.0000000000027752
work_keys_str_mv AT chenxingyu toexploretheradixpaeoniaerubrafloscarthamiherbpairspotentialmechanisminthetreatmentofischemicstrokebynetworkpharmacologyandmoleculardockingtechnology
AT wangyue toexploretheradixpaeoniaerubrafloscarthamiherbpairspotentialmechanisminthetreatmentofischemicstrokebynetworkpharmacologyandmoleculardockingtechnology
AT maying toexploretheradixpaeoniaerubrafloscarthamiherbpairspotentialmechanisminthetreatmentofischemicstrokebynetworkpharmacologyandmoleculardockingtechnology
AT wangruonan toexploretheradixpaeoniaerubrafloscarthamiherbpairspotentialmechanisminthetreatmentofischemicstrokebynetworkpharmacologyandmoleculardockingtechnology
AT zhaodexi toexploretheradixpaeoniaerubrafloscarthamiherbpairspotentialmechanisminthetreatmentofischemicstrokebynetworkpharmacologyandmoleculardockingtechnology